Leuprolide acetate 22.5 MG Injection [Lutrate] — RxCUI 2709448
RxNorm drug concept · Semantic branded drug
RxCUI 2709448
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2709448
Official nameLeuprolide acetate 22.5 MG Injection [Lutrate]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLutrate Depot 22.5 MG Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Leuprolide Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product prescribed. Fensolvi is used for children 2 and older who are going through puberty too early — a condition called central precocious puberty. Products li...
- What exactly is leuprolide injection used for?
- This is called a tumor flare, and it's actually expected. In the first one to two weeks, testosterone levels temporarily rise before the medication brings them down. For men with p...
- Why might symptoms get worse right after starting the injection?
🕸️ Concept Web — How Leuprolide acetate 22.5 MG Injection [Lutrate] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Leuprolide acetate 22.5 MG Injection [Lutrate]
RxCUI 2709448 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Leuprolide
42375IN -
Leuprolide acetate
203217PIN
-
Leuprolide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lutrate
2709443BN
-
Lutrate
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Leuprolide Injection
2606515SCDF -
Leuprolide acetate Injection
2648419SCDFP -
Leuprolide Injectable Product
1163443SCDG -
Leuprolide acetate Injectable Product
2659197SCDGP -
Leuprolide Injection [Lutrate]
2709446SBDF -
Leuprolide acetate Injection [Lutrate]
2709447SBDFP -
Lutrate Injectable Product
2709445SBDG -
Injection
1649574DF - +1 more in this family
-
Leuprolide Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Leuprolide acetate 22.5 MG Injection
2606516SCD -
Leuprolide acetate 22.5 MG
2606514SCDC -
Leuprolide acetate 22.5 MG [Lutrate]
2709444SBDC
-
Leuprolide acetate 22.5 MG Injection
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Leuprolide acetate 22.5 MG Injection
SCD · 2606516 -
Leuprolide acetate 22.5 MG
SCDC · 2606514 -
Leuprolide Injection
SCDF · 2606515 -
Leuprolide acetate Injection
SCDFP · 2648419 -
Leuprolide Injectable Product
SCDG · 1163443 -
Leuprolide acetate Injectable Product
SCDGP · 2659197
Brand-Name Concepts
-
Leuprolide acetate 22.5 MG [Lutrate]
SBDC · 2709444 -
Leuprolide Injection [Lutrate]
SBDF · 2709446 -
Leuprolide acetate Injection [Lutrate]
SBDFP · 2709447 -
Lutrate Injectable Product
SBDG · 2709445 -
Lutrate
BN · 2709443
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2709448 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 83831-0134-01 | 1 KIT in 1 CARTON (83831-134-01) * 2 mL in 1 VIAL, SINGLE-... | LUTRATE DEPOT | Avyxa Pharma, LLC | 2025-03-26 |
Observed labelers:
Avyxa Pharma, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1954 | Inj leu acet lutr dpt 7.5 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.